Effect of Omega-3 fatty acid on epicardial fat thickness in patients with acute myocardial infarction

Effects of omega-3 fatty acid on the epicardial fat thickness in patients with acute myocardial infarction underwent percutaneous coronary intervention

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0001591

Enrollment

Registered

2015-08-07

Start date

2013-09-23

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : experimental group: omega-3 fatty acid (Omacor), 2g once a day, 12 weeks, oral + conventional treatment control group: conventional treatment only

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with acute myocardial infarction underwent successful percutaneous transluminal coronary angioplasty 2. 18 years of age or older 3. informed consent before the study

Exclusion criteria

Exclusion criteria: 1. less than 90 mmHg of systolic blood pressure 2. women in pregnancy or lactation 3. past history of hypersensitivity with test drug 4. past history of hyperesnsitivity or allergy with fish 5. hepatic dysfunction (AST/ALT > 2 x upper normal)

Design outcomes

Primary

Measure	Time frame
change of epicardial fat thickness	—

Secondary

Measure	Time frame
left ventricular diastolic function	—

Countries

Korea, Republic of

Contacts

Public ContactJeong-Sook Seo

Inje University Busan Paik Hospital

orifilter@hanmail.net

Outcome results